Integrated BioPharma, Inc. (INBP)
0.189
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Integrated BioPharma Cash from Operations (Quarterly) : -1.194M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.194M |
| March 31, 2026 | 0.517M |
| December 31, 2025 | 0.617M |
| September 30, 2025 | 1.301M |
| June 30, 2025 | 0.591M |
| March 31, 2025 | 0.616M |
| December 31, 2024 | 0.201M |
| September 30, 2024 | 0.657M |
| June 30, 2024 | -0.186M |
| March 31, 2024 | 1.643M |
| December 31, 2023 | -1.827M |
| September 30, 2023 | 1.313M |
| June 30, 2023 | -1.186M |
| March 31, 2023 | 1.47M |
| December 31, 2022 | -0.044M |
| September 30, 2022 | 0.992M |
| June 30, 2022 | 2.703M |
| March 31, 2022 | 0.675M |
| December 31, 2021 | -1.388M |
| September 30, 2021 | 2.101M |
| June 30, 2021 | 0.712M |
| March 31, 2021 | 1.174M |
| December 31, 2020 | -0.754M |
| September 30, 2020 | 1.918M |
| June 30, 2020 | -2.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.491M |
| December 31, 2019 | -0.627M |
| September 30, 2019 | 1.685M |
| June 30, 2019 | 0.627M |
| March 31, 2019 | 0.615M |
| December 31, 2018 | -1.507M |
| September 30, 2018 | 0.593M |
| June 30, 2018 | -0.175M |
| March 31, 2018 | 0.703M |
| December 31, 2017 | -0.964M |
| September 30, 2017 | 1.604M |
| June 30, 2017 | -0.818M |
| March 31, 2017 | 0.668M |
| December 31, 2016 | 1.073M |
| September 30, 2016 | -0.526M |
| June 30, 2016 | 0.223M |
| March 31, 2016 | 0.339M |
| December 31, 2015 | -1.592M |
| September 30, 2015 | 0.436M |
| June 30, 2015 | -0.157M |
| March 31, 2015 | 1.514M |
| December 31, 2014 | -0.975M |
| September 30, 2014 | -0.495M |
| June 30, 2014 | -0.22M |
| March 31, 2014 | 1.097M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Medifast, Inc. | 1.697M |
| BioForce Nanosciences Holdings, Inc. | -0.027M |
| Skinvisible, Inc. | 0.0022M |
| SkyTech Orion Global Corp. | -0.16M |
| Nevis Brands, Inc. | 0.0481M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.149M |
| Cash from Financing (Quarterly) | -0.012M |
| Free Cash Flow | 0.895M |
| Free Cash Flow Per Share (Quarterly) | -0.0432 |
| Free Cash Flow to Equity (Quarterly) | -1.075M |
| Free Cash Flow to Firm (Quarterly) | -1.343M |
| Free Cash Flow Yield | 15.20% |